Status:

UNKNOWN

Repetitive Transcranial Magnetic Stimulation to Promote Regeneration in Persons With SCI

Lead Sponsor:

Kessler Foundation

Conditions:

Spinal Cord Injuries

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

This is a research study to evaluate the safety, efficacy and feasibility of high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) in patients with subacute spinal cord injury.

Detailed Description

This research study is investigating whether repetitive high-frequency transcranial magnetic stimulation (HF-rTMS) in patients with subacute spinal cord injury is safe, efficacious, and feasible. The ...

Eligibility Criteria

Inclusion

  • Be less than 8 weeks post injury
  • Must have an incomplete spinal cord injury at a neurological level of injury between the C2-C6 level and an impairment grade A, B, C, or D, according to the American Spinal Injury association (ASIA) Impairment Scale
  • If an outpatient, will be at least 6 months post injury

Exclusion

  • Have a pacemaker
  • Have metal in the skull
  • Have a history of seizures, or a brain injury
  • Being pregnant
  • Have skin issues or open wounds
  • Have severe contractures and/or spasms in my elbow/wrists as determined by study staff examination at screening
  • Study staff will review medications to determine if taking any drugs that would increase risk of having a seizure while undergoing TMS. If taking such medications, will not be enrolled

Key Trial Info

Start Date :

August 20 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2023

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05333770

Start Date

August 20 2022

End Date

August 1 2023

Last Update

October 14 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kessler Foundation

West Orange, New Jersey, United States, 07052